Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate L Parent

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|March 6, 2012
Electrochemical solid-state phase transformations of silver nanoparticlesPoonam Singh, Kate L Parent, Daniel A Buttry
Langmuir : the ACS Journal of Surfaces and Colloids|November 20, 2013
Fast-scan controlled-adsorption voltammetry for the quantification of absolute concentrations and adsorption dynamicsChristopher W Atcherley, Nicholas D Laude, Kate L Parent, et al.
Chemical Communications (Cambridge, England)|September 25, 2014
The coaction of tonic and phasic dopamine dynamicsChristopher W Atcherley, Kevin M Wood, Kate L Parent, et al.
Brain Stimulation|December 15, 2017
Differential release of dopamine in the nucleus accumbens evoked by low-versus high-frequency medial prefrontal cortex stimulationDaniel F Hill, Kate L Parent, Christopher W Atcherley, et al.
The Analyst|July 23, 2014
Fast voltammetry of metals at carbon-fiber microelectrodes: copper adsorption onto activated carbon aids rapid electrochemical analysisPavithra Pathirathna, Srimal Samaranayake, Christopher W Atcherley, et al.
Neuroscience Letters|February 15, 2014
Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical modelAndrew J Flores, Mitchell J Bartlett, Lisa Y So, et al.
Neuropharmacology|September 12, 2018
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesiaAndrew J Flores, Mitchell J Bartlett, Brandon K Root, et al.
BMC Research Notes|March 14, 2020
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelMitchell J Bartlett, Lisa Y So, Lajos Szabò, et al.
Analytical Chemistry|February 18, 2017
Platform to Enable Combined Measurement of Dopamine and Neural ActivityKate L Parent, Daniel F Hill, Lindsey M Crown, et al.
Neuroscience Letters|December 9, 2015
Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical modelMitchell J Bartlett, Ria M Joseph, Lindsey M LePoidevin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|March 6, 2012
Electrochemical solid-state phase transformations of silver nanoparticlesPoonam Singh, Kate L Parent, Daniel A Buttry
Langmuir : the ACS Journal of Surfaces and Colloids|November 20, 2013
Fast-scan controlled-adsorption voltammetry for the quantification of absolute concentrations and adsorption dynamicsChristopher W Atcherley, Nicholas D Laude, Kate L Parent, et al.
Chemical Communications (Cambridge, England)|September 25, 2014
The coaction of tonic and phasic dopamine dynamicsChristopher W Atcherley, Kevin M Wood, Kate L Parent, et al.
Brain Stimulation|December 15, 2017
Differential release of dopamine in the nucleus accumbens evoked by low-versus high-frequency medial prefrontal cortex stimulationDaniel F Hill, Kate L Parent, Christopher W Atcherley, et al.
The Analyst|July 23, 2014
Fast voltammetry of metals at carbon-fiber microelectrodes: copper adsorption onto activated carbon aids rapid electrochemical analysisPavithra Pathirathna, Srimal Samaranayake, Christopher W Atcherley, et al.
Neuroscience Letters|February 15, 2014
Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical modelAndrew J Flores, Mitchell J Bartlett, Lisa Y So, et al.
Neuropharmacology|September 12, 2018
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesiaAndrew J Flores, Mitchell J Bartlett, Brandon K Root, et al.
BMC Research Notes|March 14, 2020
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelMitchell J Bartlett, Lisa Y So, Lajos Szabò, et al.
Analytical Chemistry|February 18, 2017
Platform to Enable Combined Measurement of Dopamine and Neural ActivityKate L Parent, Daniel F Hill, Lindsey M Crown, et al.
Neuroscience Letters|December 9, 2015
Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical modelMitchell J Bartlett, Ria M Joseph, Lindsey M LePoidevin, et al.
Pageof 2